Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
6.71
-0.04 (-0.59%)
At close: Dec 5, 2025, 4:00 PM EST
6.70
-0.01 (-0.15%)
After-hours: Dec 5, 2025, 6:03 PM EST
Nuvectis Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 172 | 105 | 145 | 110 | - | - |
| Market Cap Growth | 73.07% | -27.66% | 31.58% | - | - | - |
| Enterprise Value | 136 | 87 | 122 | 86 | - | - |
| Last Close Price | 6.71 | 5.41 | 8.34 | 7.50 | - | - |
| PB Ratio | 7.17 | 10.76 | 11.84 | 7.72 | - | - |
| P/TBV Ratio | 7.16 | 10.76 | 11.84 | 7.72 | - | - |
| Quick Ratio | 3.06 | 2.08 | 2.74 | 3.23 | 2.37 | - |
| Current Ratio | 3.07 | 2.09 | 2.75 | 3.30 | 2.41 | - |
| Return on Equity (ROE) | -145.00% | -173.41% | -168.51% | -206.81% | -609.74% | - |
| Return on Assets (ROA) | -62.40% | -65.64% | -69.14% | -83.30% | - | - |
| Return on Capital (ROIC) | -94.30% | -113.21% | -103.60% | -122.13% | -171.30% | - |
| Return on Capital Employed (ROCE) | -110.00% | -204.30% | -179.50% | -126.80% | -136.70% | 240.00% |
| Earnings Yield | -16.18% | -18.18% | -15.40% | -17.38% | - | - |
| Buyback Yield / Dilution | -22.30% | -10.01% | -22.90% | -196.55% | -9.44% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.